protein design2 min read
Lila Bio lands $3.65M grant to fight pulmonary hypertension with AI-designed proteins
Seattle startup Lila Bio received a $3.65 million NIH grant to develop an AI-designed protein treatment for pulmonary hypertension. The goal is to address the underlying disease, rather than just ease symptoms, though the research is still in the lab and animal-testing stages. Read More
By Lisa StifflerGeekWire

Read the full story
Originally published by GeekWire on Nov 11, 2026.
Comments
Sign in to join the discussion.